Centessa Pharmaceuticals
Centessa Pharmaceuticals is a Healthcare & Life Sciences startup based in London, the United Kingdom, since gone public, 2 tracked investors.
About Centessa Pharmaceuticals
Centessa Pharmaceuticals is a company founded in 2020 headquartered in London, the United Kingdom. Its most recent tracked round is IPO. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Centessa Pharmaceuticals is a UK-based biotechnology company that discovers and develops medicines. Its pipeline includes orexin receptor 2 (OX2R) agonists for sleep-wake disorders (such as narcolepsy and idiopathic hypersomnia) and a proprietary LockBody antibody technology aimed at cancer therapies.
Explore Centessa Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.